ZIM Laboratories Limited (NSE:ZIMLAB)
84.34
+0.28 (0.33%)
Apr 2, 2025, 11:20 AM IST
ZIM Laboratories Revenue
ZIM Laboratories had revenue of 963.30M INR in the quarter ending December 31, 2024, with 0.04% growth. This brings the company's revenue in the last twelve months to 3.88B, up 9.35% year-over-year. In the fiscal year ending March 31, 2024, ZIM Laboratories had annual revenue of 3.68B, down -7.80%.
Revenue (ttm)
3.88B
Revenue Growth
+9.35%
P/S Ratio
n/a
Revenue / Employee
6.98M
Employees
556
Market Cap
4.09B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 3.68B | -310.92M | -7.80% |
Mar 31, 2023 | 3.99B | 651.00M | 19.52% |
Mar 31, 2022 | 3.34B | 261.64M | 8.51% |
Mar 31, 2021 | 3.07B | 295.19M | 10.63% |
Mar 31, 2020 | 2.78B | -576.16M | -17.18% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |